Publicaciones (71) Publicaciones de Enrique Otheo de Tejada Barasoain

2023

  1. Nirsevimab para la prevención de la enfermedad por virus respiratorio sincitial en niños. Posicionamiento de la Sociedad Española de Infectología Pediátrica

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 99, Núm. 4, pp. 257-263

  2. Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis

    Computer Methods and Programs in Biomedicine, Vol. 242

2022

  1. A Tool to Distinguish Viral from Bacterial Pneumonia

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 1, pp. 31-36

  2. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  3. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population

    Journal of Pediatrics, Vol. 232, pp. 287-289.e4

  2. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

  3. Prevalence of thrombotic complications in children with SARS-CoV-2

    Archives of Disease in Childhood, Vol. 106, Núm. 11, pp. 1129-1132

  4. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain

    JAMA Pediatrics

  5. Ventricular Repolarization Parameters and Coronary Involvement in Kawasaki Disease

    Journal of Pediatrics, Vol. 236, pp. 108-112.e5

2020

  1. Actualización de la situación epidemiológica de la infección por SARS-CoV-2 en España. Comentarios a las recomendaciones de manejo de la infección en pediatría

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 92, Núm. 4, pp. 239-240

  2. Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics

    Anales de Pediatria, Vol. 92, Núm. 4, pp. 239-240

2019

  1. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study

    Vaccine, Vol. 37, Núm. 16, pp. 2200-2207

  2. Multiple liver abscesses in Crohn’s disease in infliximab therapy, successfully treated with antibiotic therapy

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 6, pp. 566-568

  3. Oseltamivir for the treatment of influenza in children and adolescents

    Anales de Pediatria, Vol. 90, Núm. 5, pp. 317.e1-317.e8

  4. Oseltamivir para el tratamiento de la gripe en niños y adolescentes

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 90, Núm. 5, pp. 317-317

2018

  1. Hyponatremia in children with pneumonia rarely means SIADH

    Paediatrics and Child Health (Canada), Vol. 23, Núm. 7, pp. E126-E133

2017

  1. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial

    Journal of Pediatrics, Vol. 185, pp. 117-123.e6

  2. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015

    PLoS ONE, Vol. 12, Núm. 2

  3. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children

    Vaccine, Vol. 35, Núm. 35, pp. 4646-4651